カテゴリー： Market Monitor Global, 世界, 医療/バイオ

関節リウマチ治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Rhematoid Arthritis Drugs Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8636 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：77 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Rhematoid Arthritis Drugs Market 調査レポートは次の情報を含め、グローバルにおけるの関節リウマチ治療薬市場規模と予測を収録しています。・世界の関節リウマチ治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の関節リウマチ治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の関節リウマチ治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「医薬品」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

関節リウマチ治療薬のグローバル主要企業は、AbbVie Inc、 Hoffman-La Roche AG、 Amgen Inc、 Pfizer Inc、 Bristol-Myers Squibb Co、 Johnson & Johnson、 UCB Biosciences Inc、 Mitsubishi Tanabe Pharma Corp、 Biogen Inc、 Merck & Coなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、関節リウマチ治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の関節リウマチ治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の関節リウマチ治療薬市場：タイプ別市場シェア、2022年
・医薬品、バイオ医薬品

世界の関節リウマチ治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の関節リウマチ治療薬市場：用途別市場シェア、2022年
・処方箋、OTC

世界の関節リウマチ治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の関節リウマチ治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における関節リウマチ治療薬のグローバル売上、2018年-2023年
・主要企業における関節リウマチ治療薬のグローバル売上シェア、2022年
・主要企業における関節リウマチ治療薬のグローバル販売量、2018年-2023年
・主要企業における関節リウマチ治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
AbbVie Inc、 Hoffman-La Roche AG、 Amgen Inc、 Pfizer Inc、 Bristol-Myers Squibb Co、 Johnson & Johnson、 UCB Biosciences Inc、 Mitsubishi Tanabe Pharma Corp、 Biogen Inc、 Merck & Co

*************************************************************

・調査・分析レポートの概要
関節リウマチ治療薬市場の定義
市場セグメント
世界の関節リウマチ治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の関節リウマチ治療薬市場規模
世界の関節リウマチ治療薬市場規模：2022年 VS 2029年
世界の関節リウマチ治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの関節リウマチ治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の関節リウマチ治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：医薬品、バイオ医薬品
関節リウマチ治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：処方箋、OTC
関節リウマチ治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別関節リウマチ治療薬市場規模 2022年と2029年
地域別関節リウマチ治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
AbbVie Inc、 Hoffman-La Roche AG、 Amgen Inc、 Pfizer Inc、 Bristol-Myers Squibb Co、 Johnson & Johnson、 UCB Biosciences Inc、 Mitsubishi Tanabe Pharma Corp、 Biogen Inc、 Merck & Co
...

Rhematoid Arthritis Drugs is the drus used for Rhematoid Arthritis
This report aims to provide a comprehensive presentation of the global market for Rhematoid Arthritis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rhematoid Arthritis Drugs. This report contains market size and forecasts of Rhematoid Arthritis Drugs in global, including the following market information:
Global Rhematoid Arthritis Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Rhematoid Arthritis Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Rhematoid Arthritis Drugs companies in 2022 (%)
The global Rhematoid Arthritis Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Pharmaceuticals Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Rhematoid Arthritis Drugs include AbbVie Inc, Hoffman-La Roche AG, Amgen Inc, Pfizer Inc, Bristol-Myers Squibb Co, Johnson & Johnson, UCB Biosciences Inc, Mitsubishi Tanabe Pharma Corp and Biogen Inc, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rhematoid Arthritis Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rhematoid Arthritis Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Rhematoid Arthritis Drugs Market Segment Percentages, by Type, 2022 (%)
Pharmaceuticals
Biopharmaceuticals
Global Rhematoid Arthritis Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Rhematoid Arthritis Drugs Market Segment Percentages, by Application, 2022 (%)
Prescription
OTC
Global Rhematoid Arthritis Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Rhematoid Arthritis Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rhematoid Arthritis Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Rhematoid Arthritis Drugs revenues share in global market, 2022 (%)
Key companies Rhematoid Arthritis Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Rhematoid Arthritis Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie Inc
Hoffman-La Roche AG
Amgen Inc
Pfizer Inc
Bristol-Myers Squibb Co
Johnson & Johnson
UCB Biosciences Inc
Mitsubishi Tanabe Pharma Corp
Biogen Inc
Merck & Co
Outline of Major Chapters:
Chapter 1: Introduces the definition of Rhematoid Arthritis Drugs, market overview.
Chapter 2: Global Rhematoid Arthritis Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Rhematoid Arthritis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Rhematoid Arthritis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Rhematoid Arthritis Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Rhematoid Arthritis Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Rhematoid Arthritis Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Rhematoid Arthritis Drugs Overall Market Size
2.1 Global Rhematoid Arthritis Drugs Market Size: 2022 VS 2029
2.2 Global Rhematoid Arthritis Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Rhematoid Arthritis Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Rhematoid Arthritis Drugs Players in Global Market
3.2 Top Global Rhematoid Arthritis Drugs Companies Ranked by Revenue
3.3 Global Rhematoid Arthritis Drugs Revenue by Companies
3.4 Global Rhematoid Arthritis Drugs Sales by Companies
3.5 Global Rhematoid Arthritis Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Rhematoid Arthritis Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Rhematoid Arthritis Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Rhematoid Arthritis Drugs Players in Global Market
3.8.1 List of Global Tier 1 Rhematoid Arthritis Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Rhematoid Arthritis Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Rhematoid Arthritis Drugs Market Size Markets, 2022 & 2029
4.1.2 Pharmaceuticals
4.1.3 Biopharmaceuticals
4.2 By Type – Global Rhematoid Arthritis Drugs Revenue & Forecasts
4.2.1 By Type – Global Rhematoid Arthritis Drugs Revenue, 2018-2023
4.2.2 By Type – Global Rhematoid Arthritis Drugs Revenue, 2024-2029
4.2.3 By Type – Global Rhematoid Arthritis Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Rhematoid Arthritis Drugs Sales & Forecasts
4.3.1 By Type – Global Rhematoid Arthritis Drugs Sales, 2018-2023
4.3.2 By Type – Global Rhematoid Arthritis Drugs Sales, 2024-2029
4.3.3 By Type – Global Rhematoid Arthritis Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Rhematoid Arthritis Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Rhematoid Arthritis Drugs Market Size, 2022 & 2029
5.1.2 Prescription
5.1.3 OTC
5.2 By Application – Global Rhematoid Arthritis Drugs Revenue & Forecasts
5.2.1 By Application – Global Rhematoid Arthritis Drugs Revenue, 2018-2023
5.2.2 By Application – Global Rhematoid Arthritis Drugs Revenue, 2024-2029
5.2.3 By Application – Global Rhematoid Arthritis Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Rhematoid Arthritis Drugs Sales & Forecasts
5.3.1 By Application – Global Rhematoid Arthritis Drugs Sales, 2018-2023
5.3.2 By Application – Global Rhematoid Arthritis Drugs Sales, 2024-2029
5.3.3 By Application – Global Rhematoid Arthritis Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Rhematoid Arthritis Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Rhematoid Arthritis Drugs Market Size, 2022 & 2029
6.2 By Region – Global Rhematoid Arthritis Drugs Revenue & Forecasts
6.2.1 By Region – Global Rhematoid Arthritis Drugs Revenue, 2018-2023
6.2.2 By Region – Global Rhematoid Arthritis Drugs Revenue, 2024-2029
6.2.3 By Region – Global Rhematoid Arthritis Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Rhematoid Arthritis Drugs Sales & Forecasts
6.3.1 By Region – Global Rhematoid Arthritis Drugs Sales, 2018-2023
6.3.2 By Region – Global Rhematoid Arthritis Drugs Sales, 2024-2029
6.3.3 By Region – Global Rhematoid Arthritis Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Rhematoid Arthritis Drugs Revenue, 2018-2029
6.4.2 By Country – North America Rhematoid Arthritis Drugs Sales, 2018-2029
6.4.3 US Rhematoid Arthritis Drugs Market Size, 2018-2029
6.4.4 Canada Rhematoid Arthritis Drugs Market Size, 2018-2029
6.4.5 Mexico Rhematoid Arthritis Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Rhematoid Arthritis Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Rhematoid Arthritis Drugs Sales, 2018-2029
6.5.3 Germany Rhematoid Arthritis Drugs Market Size, 2018-2029
6.5.4 France Rhematoid Arthritis Drugs Market Size, 2018-2029
6.5.5 U.K. Rhematoid Arthritis Drugs Market Size, 2018-2029
6.5.6 Italy Rhematoid Arthritis Drugs Market Size, 2018-2029
6.5.7 Russia Rhematoid Arthritis Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Rhematoid Arthritis Drugs Market Size, 2018-2029
6.5.9 Benelux Rhematoid Arthritis Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Rhematoid Arthritis Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Rhematoid Arthritis Drugs Sales, 2018-2029
6.6.3 China Rhematoid Arthritis Drugs Market Size, 2018-2029
6.6.4 Japan Rhematoid Arthritis Drugs Market Size, 2018-2029
6.6.5 South Korea Rhematoid Arthritis Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Rhematoid Arthritis Drugs Market Size, 2018-2029
6.6.7 India Rhematoid Arthritis Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Rhematoid Arthritis Drugs Revenue, 2018-2029
6.7.2 By Country – South America Rhematoid Arthritis Drugs Sales, 2018-2029
6.7.3 Brazil Rhematoid Arthritis Drugs Market Size, 2018-2029
6.7.4 Argentina Rhematoid Arthritis Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Rhematoid Arthritis Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Rhematoid Arthritis Drugs Sales, 2018-2029
6.8.3 Turkey Rhematoid Arthritis Drugs Market Size, 2018-2029
6.8.4 Israel Rhematoid Arthritis Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Rhematoid Arthritis Drugs Market Size, 2018-2029
6.8.6 UAE Rhematoid Arthritis Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 AbbVie Inc
7.1.1 AbbVie Inc Company Summary
7.1.2 AbbVie Inc Business Overview
7.1.3 AbbVie Inc Rhematoid Arthritis Drugs Major Product Offerings
7.1.4 AbbVie Inc Rhematoid Arthritis Drugs Sales and Revenue in Global (2018-2023)
7.1.5 AbbVie Inc Key News & Latest Developments
7.2 Hoffman-La Roche AG
7.2.1 Hoffman-La Roche AG Company Summary
7.2.2 Hoffman-La Roche AG Business Overview
7.2.3 Hoffman-La Roche AG Rhematoid Arthritis Drugs Major Product Offerings
7.2.4 Hoffman-La Roche AG Rhematoid Arthritis Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Hoffman-La Roche AG Key News & Latest Developments
7.3 Amgen Inc
7.3.1 Amgen Inc Company Summary
7.3.2 Amgen Inc Business Overview
7.3.3 Amgen Inc Rhematoid Arthritis Drugs Major Product Offerings
7.3.4 Amgen Inc Rhematoid Arthritis Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Amgen Inc Key News & Latest Developments
7.4 Pfizer Inc
7.4.1 Pfizer Inc Company Summary
7.4.2 Pfizer Inc Business Overview
7.4.3 Pfizer Inc Rhematoid Arthritis Drugs Major Product Offerings
7.4.4 Pfizer Inc Rhematoid Arthritis Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Pfizer Inc Key News & Latest Developments
7.5 Bristol-Myers Squibb Co
7.5.1 Bristol-Myers Squibb Co Company Summary
7.5.2 Bristol-Myers Squibb Co Business Overview
7.5.3 Bristol-Myers Squibb Co Rhematoid Arthritis Drugs Major Product Offerings
7.5.4 Bristol-Myers Squibb Co Rhematoid Arthritis Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Bristol-Myers Squibb Co Key News & Latest Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Rhematoid Arthritis Drugs Major Product Offerings
7.6.4 Johnson & Johnson Rhematoid Arthritis Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Johnson & Johnson Key News & Latest Developments
7.7 UCB Biosciences Inc
7.7.1 UCB Biosciences Inc Company Summary
7.7.2 UCB Biosciences Inc Business Overview
7.7.3 UCB Biosciences Inc Rhematoid Arthritis Drugs Major Product Offerings
7.7.4 UCB Biosciences Inc Rhematoid Arthritis Drugs Sales and Revenue in Global (2018-2023)
7.7.5 UCB Biosciences Inc Key News & Latest Developments
7.8 Mitsubishi Tanabe Pharma Corp
7.8.1 Mitsubishi Tanabe Pharma Corp Company Summary
7.8.2 Mitsubishi Tanabe Pharma Corp Business Overview
7.8.3 Mitsubishi Tanabe Pharma Corp Rhematoid Arthritis Drugs Major Product Offerings
7.8.4 Mitsubishi Tanabe Pharma Corp Rhematoid Arthritis Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Mitsubishi Tanabe Pharma Corp Key News & Latest Developments
7.9 Biogen Inc
7.9.1 Biogen Inc Company Summary
7.9.2 Biogen Inc Business Overview
7.9.3 Biogen Inc Rhematoid Arthritis Drugs Major Product Offerings
7.9.4 Biogen Inc Rhematoid Arthritis Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Biogen Inc Key News & Latest Developments
7.10 Merck & Co
7.10.1 Merck & Co Company Summary
7.10.2 Merck & Co Business Overview
7.10.3 Merck & Co Rhematoid Arthritis Drugs Major Product Offerings
7.10.4 Merck & Co Rhematoid Arthritis Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Merck & Co Key News & Latest Developments
8 Global Rhematoid Arthritis Drugs Production Capacity, Analysis
8.1 Global Rhematoid Arthritis Drugs Production Capacity, 2018-2029
8.2 Rhematoid Arthritis Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Rhematoid Arthritis Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Rhematoid Arthritis Drugs Supply Chain Analysis
10.1 Rhematoid Arthritis Drugs Industry Value Chain
10.2 Rhematoid Arthritis Drugs Upstream Market
10.3 Rhematoid Arthritis Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Rhematoid Arthritis Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Rhematoid Arthritis Drugs in Global Market
Table 2. Top Rhematoid Arthritis Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Rhematoid Arthritis Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Rhematoid Arthritis Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Rhematoid Arthritis Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Rhematoid Arthritis Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Rhematoid Arthritis Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Rhematoid Arthritis Drugs Product Type
Table 9. List of Global Tier 1 Rhematoid Arthritis Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rhematoid Arthritis Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Rhematoid Arthritis Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Rhematoid Arthritis Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Rhematoid Arthritis Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Rhematoid Arthritis Drugs Sales (K Units), 2024-2029
Table 16. By Application – Global Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Rhematoid Arthritis Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Rhematoid Arthritis Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Rhematoid Arthritis Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Rhematoid Arthritis Drugs Sales (K Units), 2024-2029
Table 21. By Region – Global Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Rhematoid Arthritis Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Rhematoid Arthritis Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Rhematoid Arthritis Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Rhematoid Arthritis Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Rhematoid Arthritis Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Rhematoid Arthritis Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Rhematoid Arthritis Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Rhematoid Arthritis Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Rhematoid Arthritis Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Rhematoid Arthritis Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Rhematoid Arthritis Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Rhematoid Arthritis Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Rhematoid Arthritis Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Rhematoid Arthritis Drugs Sales, (K Units), 2024-2029
Table 46. AbbVie Inc Company Summary
Table 47. AbbVie Inc Rhematoid Arthritis Drugs Product Offerings
Table 48. AbbVie Inc Rhematoid Arthritis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. AbbVie Inc Key News & Latest Developments
Table 50. Hoffman-La Roche AG Company Summary
Table 51. Hoffman-La Roche AG Rhematoid Arthritis Drugs Product Offerings
Table 52. Hoffman-La Roche AG Rhematoid Arthritis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Hoffman-La Roche AG Key News & Latest Developments
Table 54. Amgen Inc Company Summary
Table 55. Amgen Inc Rhematoid Arthritis Drugs Product Offerings
Table 56. Amgen Inc Rhematoid Arthritis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Amgen Inc Key News & Latest Developments
Table 58. Pfizer Inc Company Summary
Table 59. Pfizer Inc Rhematoid Arthritis Drugs Product Offerings
Table 60. Pfizer Inc Rhematoid Arthritis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Pfizer Inc Key News & Latest Developments
Table 62. Bristol-Myers Squibb Co Company Summary
Table 63. Bristol-Myers Squibb Co Rhematoid Arthritis Drugs Product Offerings
Table 64. Bristol-Myers Squibb Co Rhematoid Arthritis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Bristol-Myers Squibb Co Key News & Latest Developments
Table 66. Johnson & Johnson Company Summary
Table 67. Johnson & Johnson Rhematoid Arthritis Drugs Product Offerings
Table 68. Johnson & Johnson Rhematoid Arthritis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Johnson & Johnson Key News & Latest Developments
Table 70. UCB Biosciences Inc Company Summary
Table 71. UCB Biosciences Inc Rhematoid Arthritis Drugs Product Offerings
Table 72. UCB Biosciences Inc Rhematoid Arthritis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. UCB Biosciences Inc Key News & Latest Developments
Table 74. Mitsubishi Tanabe Pharma Corp Company Summary
Table 75. Mitsubishi Tanabe Pharma Corp Rhematoid Arthritis Drugs Product Offerings
Table 76. Mitsubishi Tanabe Pharma Corp Rhematoid Arthritis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Mitsubishi Tanabe Pharma Corp Key News & Latest Developments
Table 78. Biogen Inc Company Summary
Table 79. Biogen Inc Rhematoid Arthritis Drugs Product Offerings
Table 80. Biogen Inc Rhematoid Arthritis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Biogen Inc Key News & Latest Developments
Table 82. Merck & Co Company Summary
Table 83. Merck & Co Rhematoid Arthritis Drugs Product Offerings
Table 84. Merck & Co Rhematoid Arthritis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Merck & Co Key News & Latest Developments
Table 86. Rhematoid Arthritis Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Rhematoid Arthritis Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Rhematoid Arthritis Drugs Production by Region, 2018-2023 (K Units)
Table 89. Global Rhematoid Arthritis Drugs Production by Region, 2024-2029 (K Units)
Table 90. Rhematoid Arthritis Drugs Market Opportunities & Trends in Global Market
Table 91. Rhematoid Arthritis Drugs Market Drivers in Global Market
Table 92. Rhematoid Arthritis Drugs Market Restraints in Global Market
Table 93. Rhematoid Arthritis Drugs Raw Materials
Table 94. Rhematoid Arthritis Drugs Raw Materials Suppliers in Global Market
Table 95. Typical Rhematoid Arthritis Drugs Downstream
Table 96. Rhematoid Arthritis Drugs Downstream Clients in Global Market
Table 97. Rhematoid Arthritis Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Rhematoid Arthritis Drugs Segment by Type in 2022
Figure 2. Rhematoid Arthritis Drugs Segment by Application in 2022
Figure 3. Global Rhematoid Arthritis Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Rhematoid Arthritis Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Rhematoid Arthritis Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Rhematoid Arthritis Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Rhematoid Arthritis Drugs Revenue in 2022
Figure 9. By Type - Global Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Rhematoid Arthritis Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Rhematoid Arthritis Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Rhematoid Arthritis Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Rhematoid Arthritis Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Rhematoid Arthritis Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Rhematoid Arthritis Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Rhematoid Arthritis Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Rhematoid Arthritis Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Rhematoid Arthritis Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Rhematoid Arthritis Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Rhematoid Arthritis Drugs Sales Market Share, 2018-2029
Figure 23. US Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Rhematoid Arthritis Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Rhematoid Arthritis Drugs Sales Market Share, 2018-2029
Figure 28. Germany Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Rhematoid Arthritis Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Rhematoid Arthritis Drugs Sales Market Share, 2018-2029
Figure 37. China Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Rhematoid Arthritis Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Rhematoid Arthritis Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Rhematoid Arthritis Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Rhematoid Arthritis Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Rhematoid Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Rhematoid Arthritis Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Rhematoid Arthritis Drugs by Region, 2022 VS 2029
Figure 54. Rhematoid Arthritis Drugs Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 関節リウマチ治療薬の世界市場見通し2023年-2029年(Rhematoid Arthritis Drugs Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

関節リウマチ治療薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp